{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:43:39Z","timestamp":1791236619256,"version":"4.1.0"},"reference-count":96,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["tuberculosisjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.tube.2014.10.004","type":"journal-article","created":{"date-parts":[[2014,10,22]],"date-time":"2014-10-22T19:56:48Z","timestamp":1414007808000},"page":"6-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["The present and future of tuberculosis vaccinations"],"prefix":"10.1016","volume":"95","author":[{"given":"Nicola","family":"Principi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tube.2014.10.004_bib1","series-title":"Global tuberculosis report","author":"World Health Organization","year":"2013"},{"key":"10.1016\/j.tube.2014.10.004_bib2","doi-asserted-by":"crossref","first-page":"279","DOI":"10.7861\/clinmedicine.14-3-279","article-title":"Multidrug-resistant and extensively drug-resistant tuberculosis: a review of current concepts and future challenges","volume":"14","author":"G\u00fcnther","year":"2014","journal-title":"Clin Med"},{"key":"10.1016\/j.tube.2014.10.004_bib3","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/07853890310005713","article-title":"The world-wide increase in tuberculosis: how demographic changes, HIV infection and increasing numbers in poverty are increasing tuberculosis","volume":"35","author":"Davies","year":"2003","journal-title":"Ann Med"},{"key":"10.1016\/j.tube.2014.10.004_bib4","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0277-9536(94)90095-7","article-title":"Immunization programs and their costs","volume":"39","author":"Brenzel","year":"1994","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.tube.2014.10.004_bib5","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/cid\/cit790","article-title":"Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials","volume":"58","author":"Mangtani","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tube.2014.10.004_bib6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1542\/peds.96.1.29","article-title":"The efficacy of bacillus Calmette-Gu\u00e9rin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature","volume":"96","author":"Colditz","year":"1995","journal-title":"Pediatrics"},{"key":"10.1016\/j.tube.2014.10.004_bib7","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.tube.2014.10.004_bib8","first-page":"819","article-title":"Trial of BCG vaccines in south India for tuberculosis prevention: first report 144","volume":"57","author":"No authors listed","year":"1979","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.tube.2014.10.004_bib9","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/oxfordjournals.bmb.a072277","article-title":"BCG vaccination against tuberculosis and leprosy","volume":"44","author":"Fine","year":"1988","journal-title":"Br Med Bull"},{"key":"10.1016\/j.tube.2014.10.004_bib10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.vaccine.2006.07.020","article-title":"The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children","volume":"25","author":"Hesseling","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2014.10.004_bib11","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/j.vaccine.2008.02.038","article-title":"Assessing the impact of different BCG vaccination strategies on severe childhood TB in low-intermediate prevalence settings","volume":"26","author":"Manissero","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2014.10.004_bib12","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S0140-6736(05)67145-0","article-title":"Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial","volume":"366","author":"Rodrigues","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.tube.2014.10.004_bib13","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/0008-8749(73)90193-7","article-title":"Importance of thymus-derived lymphocytes in cell-mediated immunity to infection","volume":"7","author":"North","year":"1973","journal-title":"Cell Immunol"},{"key":"10.1016\/j.tube.2014.10.004_bib14","doi-asserted-by":"crossref","first-page":"518","DOI":"10.4049\/jimmunol.151.1.518","article-title":"Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection","volume":"151","author":"Orme","year":"1993","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.tube.2014.10.004_bib15","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1348-0421.1986.tb00952.x","article-title":"Determination of the T-cell subset producing gamma-interferon in tuberculous pleural effusion","volume":"30","author":"Shimokata","year":"1986","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.tube.2014.10.004_bib16","doi-asserted-by":"crossref","first-page":"e19105","DOI":"10.1371\/journal.pone.0019105","article-title":"Interferon gamma activated macrophages kill mycobacteria by nitric oxide induced apoptosis","volume":"6","author":"Herbst","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2014.10.004_bib17","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1084\/jem.178.6.2243","article-title":"Disseminated tuberculosis in Interferon \u03b3 gene-disrupted mice","volume":"178","author":"Cooper","year":"1983","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.tube.2014.10.004_bib18","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.0105-2896.2005.00227.x","article-title":"Defects in the interferon-gamma and interleukin-12 pathways","volume":"203","author":"Rosenzweig","year":"2005","journal-title":"Immunol Rev"},{"key":"10.1016\/j.tube.2014.10.004_bib19","doi-asserted-by":"crossref","first-page":"e1002464","DOI":"10.1371\/journal.ppat.1002464","article-title":"Tuberculosis and HIV co-infection","volume":"8","author":"Pawlowski","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.tube.2014.10.004_bib20","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/QCO.0b013e32832dda55","article-title":"Infectious complications of tumor necrosis factor blockade","volume":"22","author":"Wallis","year":"2009","journal-title":"Curr Opin Infect Dis"},{"issue":"Suppl.\u00a05","key":"10.1016\/j.tube.2014.10.004_bib21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/1469-0691.12460","article-title":"Critical research concepts in tuberculosis vaccine development","volume":"20","author":"Delogu","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.tube.2014.10.004_bib22","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.it.2012.03.004","article-title":"Tuberculosis vaccine development: strength lies in tenacity","volume":"33","author":"Kaufmann","year":"2012","journal-title":"Trends Immunol"},{"key":"10.1016\/j.tube.2014.10.004_bib23","doi-asserted-by":"crossref","first-page":"13853","DOI":"10.1073\/pnas.250480397","article-title":"Recombinant BCG vaccines expressing the Mycobacterium tuberculosis 30 kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model","volume":"97","author":"Horwitz","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.tube.2014.10.004_bib24","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1073\/pnas.92.5.1530","article-title":"Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis","volume":"92","author":"Horwitz","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.tube.2014.10.004_bib25","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1172\/JCI118028","article-title":"Identification of macrophage and stress induced proteins of Mycobacterium tuberculosis","volume":"96","author":"Lee","year":"1995","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.tube.2014.10.004_bib26","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1128\/IAI.64.8.3038-3047.1996","article-title":"Novel insights into the genetics, biochemistry, and immunocytochemistry of the 30-kilodalton major extracellular protein of Mycobacterium tuberculosis","volume":"64","author":"Harth","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2014.10.004_bib27","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1128\/IAI.71.4.1672-1679.2003","article-title":"A\u00a0new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis","volume":"71","author":"Horwitz","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2014.10.004_bib28","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1086\/592450","article-title":"A\u00a0new recombinant bacille Calmette-Gu\u00e9rin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers","volume":"198","author":"Hoft","year":"2008","journal-title":"J\u00a0Infect Dis"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.tube.2014.10.004_bib29","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/1471-2334-14-S1-S2","article-title":"Vaccine against tuberculosis: what's new?","volume":"14","author":"Montagnani","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.tube.2014.10.004_bib30","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/infdis\/jir592","article-title":"Recombinant BCG \u0394ureC hly+ induces superior protection over parental BCG by stimulating a balanced combination of type 1 and type 17 cytokine responses","volume":"204","author":"Desel","year":"2011","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.tube.2014.10.004_bib31","doi-asserted-by":"crossref","first-page":"7608","DOI":"10.1016\/j.vaccine.2012.10.031","article-title":"The recombinant tuberculosis vaccine rBCG \u0394ureC:hly(+) induces apoptotic vesicles for improved priming of CD4(+) and CD8(+) T cells","volume":"30","author":"Farinacci","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2014.10.004_bib32","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.vaccine.2012.12.053","article-title":"Safety and immunogenicity of the recombinant BCG vaccine VPM1002 in a phase 1 open-label randomized clinical trial","volume":"31","author":"Grode","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2014.10.004_bib33","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1126\/science.334.6062.1488","article-title":"Infectious disease. Taking a new shot at a TB vaccine","volume":"334","author":"Kupferschmidt","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.tube.2014.10.004_bib34","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.copbio.2012.03.007","article-title":"Recombinant live vaccine candidates against tuberculosis","volume":"23","author":"Kaufmann","year":"2012","journal-title":"Curr Opin Biotechnol"},{"key":"10.1016\/j.tube.2014.10.004_bib35","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.1365-2958.2001.02500.x","article-title":"An essential role for phoP in Mycobacterium tuberculosis virulence","volume":"41","author":"Perez","year":"2011","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.tube.2014.10.004_bib36","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1016\/j.vaccine.2013.07.051","article-title":"Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials","volume":"31","author":"Arbues","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2014.10.004_bib37","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1365-2249.2006.03284.x","article-title":"Immunological responses and protective immunity against tuberculosis conferred by vaccination of Balb\/C mice with the attenuated Mycobacterium tuberculosis (phoP) SO2 strain","volume":"147","author":"Aguilar","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.tube.2014.10.004_bib38","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1016\/j.vaccine.2009.02.060","article-title":"Extended safety studies of the attenuated live tuberculosis vaccine SO2 based on phoP mutant","volume":"27","author":"Cardona","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2014.10.004_bib39","doi-asserted-by":"crossref","first-page":"e5264","DOI":"10.1371\/journal.pone.0005264","article-title":"MVA.85A boosting of BCG and an attenuated, phoP deficient M. tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques","volume":"4","author":"Verreck","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2014.10.004_bib40","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1016\/j.vaccine.2006.03.017","article-title":"The live Mycobacterium tuberculosis phoP mutant strain is more attenuated than BCG and confers protective immunity against tuberculosis in mice and guinea pigs","volume":"24","author":"Martin","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2014.10.004_bib41","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/eji.201141903","article-title":"Protective immunity afforded by attenuated, PhoP-deficient Mycobacterium tuberculosis is associated with sustained generation of CD4(+) T-cell memory","volume":"42","author":"Nambiar","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.tube.2014.10.004_bib42","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1016\/j.vaccine.2005.03.001","article-title":"New live mycobacterial vaccines: the Geneva consensus on essential steps towards clinical development","volume":"29","author":"Kamath","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2014.10.004_bib43","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/nm.2420","article-title":"A\u00a0recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosis","volume":"17","author":"Sweeney","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.tube.2014.10.004_bib44","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1164\/arrd.1983.127.5.599","article-title":"Kinetics of the delayed-type hypersensitivity response in tuberculous guinea pigs and mice tested with several mycobacterial antigen preparations","volume":"127","author":"Collins","year":"1983","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.tube.2014.10.004_bib45","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1016\/j.vaccine.2014.03.047","article-title":"Therapeutic vaccines for tuberculosis\u2013a systematic review","volume":"32","author":"Gr\u00f6schel","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2014.10.004_bib46","doi-asserted-by":"crossref","first-page":"7652","DOI":"10.1016\/j.vaccine.2010.09.041","article-title":"Immunogenicity of a protective whole cell mycobacterial vaccine in HIV-infected adults: a phase III study in Tanzania","volume":"28","author":"Lahey","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2014.10.004_bib47","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1586\/erv.13.15","article-title":"Development of chimpanzee adenoviruses as vaccine vectors: challenges and successes emerging from clinical trials","volume":"12","author":"Capone","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.tube.2014.10.004_bib48","doi-asserted-by":"crossref","first-page":"8263","DOI":"10.1128\/JVI.77.15.8263-8271.2003","article-title":"Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity","volume":"77","author":"Vogels","year":"2003","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.tube.2014.10.004_bib49","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1128\/IAI.00004-07","article-title":"Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon","volume":"75","author":"Radosevic","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2014.10.004_bib50","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1164\/rccm.200910-1484OC","article-title":"The novel tuberculosis vaccine, AERAS-402, induces robust and polyfunctional CD4+ and CD8+ T cells in adults","volume":"181","author":"Abel","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.tube.2014.10.004_bib51","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1016\/j.vaccine.2012.01.048","article-title":"A\u00a0recombinant adenovirus expressing immunodominant TB antigens can significantly enhance BCG-induced human immunity","volume":"30","author":"Hoft","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2014.10.004_bib52","doi-asserted-by":"crossref","DOI":"10.4161\/hv.29108","article-title":"A\u00a0nonhuman primate toxicology and immunogenicity study evaluating aerosol delivery of AERAS-402\/Ad35 vaccine: evidence for transient T cell responses in peripheral blood and robust sustained responses in the lungs","author":"Hokey","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.tube.2014.10.004_bib53","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/nm1128","article-title":"Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans","volume":"10","author":"McShane","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.tube.2014.10.004_bib54","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1128\/IAI.00287-09","article-title":"Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis","volume":"77","author":"Vordermeier","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2014.10.004_bib55","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1128\/IAI.73.6.3814-3816.2005","article-title":"Boosting with poxviruses enhances Mycobacterium bovis BCG efficacy against tuberculosis in guinea pigs","volume":"73","author":"Williams","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2014.10.004_bib56","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1086\/590185","article-title":"Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa","volume":"198","author":"Hawkridge","year":"2008","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.tube.2014.10.004_bib57","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0140-6736(13)60177-4","article-title":"Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial","volume":"381","author":"Tameris","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.tube.2014.10.004_bib58","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1016\/j.vaccine.2012.05.035","article-title":"Improved CD4+ T cell responses to Mycobacterium tuberculosis in PPD-negative adults by M72\/AS01 as compared to the M72\/AS02 and Mtb72F\/AS02 tuberculosis candidate vaccine formulations: a randomized trial","volume":"31","author":"Leroux-Roels","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2014.10.004_bib59","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1164\/rccm.201208-1385OC","article-title":"Induction and regulation of T cell immunity by the novel TB vaccine M72\/AS01 in South African adults","volume":"188","author":"Day","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.tube.2014.10.004_bib60","unstructured":"Tait D. Progress of the M72\/AS01E tuberculosis vaccine candidate into phase IIb efficacy trial. Presented at: TB Vaccines Third Global Forum; 2013 March 25\u201327; Cape Town, South Africa."},{"key":"10.1016\/j.tube.2014.10.004_bib61","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1016\/j.vaccine.2010.02.094","article-title":"Ag85B-ESAT-6 adjuvanted with IC31 promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naive human volunteers","volume":"28","author":"van Dissel","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2014.10.004_bib62","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/j.vaccine.2010.12.135","article-title":"Ag85B-ESAT-6 adjuvanted with IC31\u00ae promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection","volume":"29","author":"van Dissel","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2014.10.004_bib63","doi-asserted-by":"crossref","first-page":"235","DOI":"10.7774\/cevr.2014.3.2.235","article-title":"DNA immunization of Mycobacterium tuberculosis resuscitation-promoting factor B elicits polyfunctional CD8(+) T cell responses","volume":"3","author":"Lee","year":"2014","journal-title":"Clin Exp Vaccine Res"},{"key":"10.1016\/j.tube.2014.10.004_bib64","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.4049\/jimmunol.1301161","article-title":"Protection against tuberculosis with homologous or heterologous protein\/vector vaccine approaches is not dependent on CD8+ T cells","volume":"191","author":"Baldwin","year":"2013","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.tube.2014.10.004_bib65","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1126\/scitranslmed.3001094","article-title":"A\u00a0defined tuberculosis vaccine candidate boosts BCG and protects against multidrug-resistant Mycobacterium tuberculosis","volume":"2","author":"Bertholet","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.tube.2014.10.004_bib66","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1172\/JCI46252","article-title":"The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection","volume":"122","author":"Lin","year":"2012","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.tube.2014.10.004_bib67","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.tube.2006.01.024","article-title":"RUTI: a new chance to shorten the treatment of latent tuberculosis infection","volume":"86","author":"Cardona","year":"2006","journal-title":"Tuberculosis"},{"key":"10.1016\/j.tube.2014.10.004_bib68","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1128\/CVI.00094-08","article-title":"Induction of a specific strong polyantigenic cellular immune response after short-term chemotherapy controls bacillary reactivation in murine and guinea pig experimental models of tuberculosis","volume":"15","author":"Guirado","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.tube.2014.10.004_bib69","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nrmicro3230","article-title":"In search of a new paradigm for protective immunity to TB","volume":"12","author":"Nunes-Alves","year":"2014","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.tube.2014.10.004_bib70","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/1074-7613(95)90001-2","article-title":"Tumor necrosis factor-\u03b1 is required in the protective immune response against Mycobacterium tuberculosis in mice","volume":"2","author":"Flynn","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/j.tube.2014.10.004_bib71","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.4049\/jimmunol.0904189","article-title":"Caspase-1 independent IL-1\u03b2 production is critical for host resistance to Mycobacterium tuberculosis and does not require TLR signaling in\u00a0vivo","volume":"184","author":"Mayer-Barber","year":"2010","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.tube.2014.10.004_bib72","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1189\/jlb.1204723","article-title":"Disruption of granulocyte macrophage-colony stimulating factor production in the lungs severely affects the ability of mice to control Mycobacterium tuberculosis infection","volume":"77","author":"Gonzalez-Juarrero","year":"2005","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.tube.2014.10.004_bib73","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.4049\/jimmunol.1201061","article-title":"Blockade of IL-10 signaling during bacillus Calmette-Guerin vaccination enhances and sustains TH1, TH17, and innate lymphoid IFN-\u03b3 and IL-17 responses and increases protection to Mycobacterium tuberculosis infection","volume":"189","author":"Pitt","year":"2012","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.tube.2014.10.004_bib74","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1164\/rccm.201006-0974OC","article-title":"Negative and positive predictive value of a whole-blood interferon-\u03b3 release assay for developing active tuberculosis: an update","volume":"183","author":"Diel","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.tube.2014.10.004_bib75","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1098\/rstb.2011.0316","article-title":"Host-pathogen coevolution in human tuberculosis","volume":"367","author":"Gagneux","year":"2012","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.tube.2014.10.004_bib76","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1365-2249.2004.02518.x","article-title":"T\u00a0cell-derived tumour necrosis factor is essential, but not sufficient, for protection against Mycobacterium tuberculosis infection","volume":"137","author":"Saunders","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.tube.2014.10.004_bib77","doi-asserted-by":"crossref","first-page":"5896","DOI":"10.4049\/jimmunol.1200990","article-title":"The Tim3-galectin 9 pathway induces antibacterial activity in human macrophages infected with Mycobacterium tuberculosis","volume":"189","author":"Sada-Ovalle","year":"2012","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.tube.2014.10.004_bib78","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1038\/ncomms2898","article-title":"Mycobacterium tuberculosis is extraordinarily sensitive to killing by a vitamin C-induced Fenton reaction","volume":"4","author":"Vilcheze","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.tube.2014.10.004_bib79","doi-asserted-by":"crossref","first-page":"e1003407","DOI":"10.1371\/journal.ppat.1003407","article-title":"Vitamin D induces interleukin-1\u03b2 expression: paracrine macrophage epithelial signaling controls M.\u00a0tuberculosis infection","volume":"9","author":"Verway","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.tube.2014.10.004_bib80","doi-asserted-by":"crossref","first-page":"e1000392","DOI":"10.1371\/journal.ppat.1000392","article-title":"A\u00a0critical role for CD8 T cells in a nonhuman primate model of tuberculosis","volume":"5","author":"Chen","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.tube.2014.10.004_bib81","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1046\/j.1365-2567.2003.01731.x","article-title":"Cytotoxic T-cell responses to Mycobacterium bovis during experimental infection of cattle with bovine tuberculosis","volume":"110","author":"Skinner","year":"2003","journal-title":"Immunology"},{"key":"10.1016\/j.tube.2014.10.004_bib82","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1615\/CritRevImmunol.v26.i4.30","article-title":"Mycobacterium tuberculosis-specific CD8+ T cells and their role in immunity","volume":"26","author":"Woodworth","year":"2006","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.tube.2014.10.004_bib83","doi-asserted-by":"crossref","first-page":"8595","DOI":"10.4049\/jimmunol.181.12.8595","article-title":"Mycobacterium tuberculosis-specific CD8+ T cells require perforin to kill target cells and provide protection in\u00a0vivo","volume":"181","author":"Woodworth","year":"2008","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.tube.2014.10.004_bib84","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.immunol.25.022106.141623","article-title":"Regulatory T cells: mechanisms of differentiation and function","volume":"30","author":"Josefowicz","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.tube.2014.10.004_bib85","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nature04444","article-title":"Restoring function in exhausted CD8 T cells during chronic viral infection","volume":"439","author":"Barber","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.tube.2014.10.004_bib86","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.clim.2007.12.005","article-title":"Alteration of the relative levels of iNKT cell subsets is associated with chronic mycobacterial infections","volume":"127","author":"Im","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1016\/j.tube.2014.10.004_bib87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clim.2007.12.006","article-title":"Invariant NKT cells from HIV-1 or Mycobacterium tuberculosis-infected patients express an activated phenotype","volume":"127","author":"Montoya","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1016\/j.tube.2014.10.004_bib88","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/ni.2630","article-title":"A\u00a0conserved human T cell population targets mycobacterial antigens presented by CD1b","volume":"14","author":"Van Rhijn","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1016\/j.tube.2014.10.004_bib89","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1172\/JCI115053","article-title":"Selective expansion of human gamma delta T cells by monocytes infected with live Mycobacterium tuberculosis","volume":"87","author":"Havlir","year":"1991","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.tube.2014.10.004_bib90","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/ni.1890","article-title":"Antimicrobial activity of mucosal-associated invariant T cells","volume":"11","author":"Le Bourhis","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.tube.2014.10.004_bib91","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.4049\/jimmunol.180.3.1962","article-title":"Distinct, specific IL-17- and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response","volume":"180","author":"Scriba","year":"2008","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.tube.2014.10.004_bib92","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.chom.2013.02.009","article-title":"Antibody-mediated immunity against tuberculosis: implications for vaccine development","volume":"13","author":"Achkar","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.tube.2014.10.004_bib93","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1128\/IAI.68.1.335-341.2000","article-title":"Clearance and organ distribution of Mycobacterium tuberculosis lipoarabinomannan (LAM) in the presence and absence of LAM binding immunoglobulin M","volume":"68","author":"Glatman-Freedman","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2014.10.004_bib94","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1002\/eji.200425045","article-title":"Complement activation by necrotic cells in normal plasma environment compares to that by late apoptotic cells and involves predominantly IgM","volume":"34","author":"Ciurana","year":"2004","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.tube.2014.10.004_bib95","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jaci.2010.10.030","article-title":"The IgG molecule as a biological immune response modifier: mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders","volume":"127","author":"Ballow","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.tube.2014.10.004_bib96","doi-asserted-by":"crossref","DOI":"10.4161\/hv.29574","article-title":"Multivalent TB vaccines targeting the esx gene family generate potent and broad cell-mediated immune responses superior to BCG","author":"Villarreal","year":"2014","journal-title":"Hum Vaccine Immunother"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979214205701?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979214205701?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T13:36:17Z","timestamp":1689600977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472979214205701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":96,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S1472979214205701"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2014.10.004","relation":{},"ISSN":["1472-9792"],"issn-type":[{"value":"1472-9792","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The present and future of tuberculosis vaccinations","name":"articletitle","label":"Article Title"},{"value":"Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tube.2014.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}